Back to today’s briefing

Story perspectives

Critics Challenge Chemical Imbalance Myth in Depression Treatment

7/8/2025

41 10

Summary

Story summary

Recent critiques challenge the long-standing belief that depression is merely a chemical imbalance, labeling it misleading and harmful. Despite calls for change, UK and New Zealand regulators have overlooked the need to amend antidepressant packaging. Critics emphasize that SSRIs provide limited benefits while carrying serious risks, urging a greater focus on psychotherapy and a reevaluation of mental health policies.

1 of 1

Story summary

Recent critiques challenge the long-standing belief that depression is merely a chemical imbalance, labeling it misleading and harmful. Despite calls for change, UK and New Zealand regulators have overlooked the need to amend antidepressant packaging. Critics emphasize that SSRIs provide limited benefits while carrying serious risks, urging a greater focus on psychotherapy and a reevaluation of mental health policies.